ANI Pharmaceuticals is scheduled to present at a conference involving H.C. Wainwright and Morgan Stanley, led by CEO Nikhil Lalwani.
3 reports, 1 independent
Updated Jul 24
Gone quiet
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
ANI Pharmaceuticals is scheduled to present at a conference involving H.C. Wainwright and Morgan Stanley, led by CEO Nikhil Lalwani.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
ANI Pharmaceuticals (United States)
company in Baudette, United States
Coverage
Newest first; wire copies grouped- GlobeNewswireANI Pharmaceuticals to Present at Upcoming Investor Conferences PRINCETON, N.J., Aug. 25, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced th
- GlobeNewswireANI Pharmaceuticals Reports Record Second Quarter 2025 Financial Results and Raises 2025 Guidance Generated record quarterly net revenues of $211.4 million, representing year-over-year growth of 53.1